Eculizumab hematology data

Data from an ongoing extension study of a previously reported U.K. Phase Ib trial in

Read the full 155 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE